These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 29379923)

  • 1. Synthesis, isomerisation and biological properties of mononuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand.
    Sun B; Southam HM; Butler JA; Poole RK; Burgun A; Tarzia A; Keene FR; Collins JG
    Dalton Trans; 2018 Feb; 47(7):2422-2434. PubMed ID: 29379923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Antimicrobial Activity of Mononuclear Ruthenium(II) Complexes Containing the dppz Ligand.
    Liu X; Sun B; Kell REM; Southam HM; Butler JA; Li X; Poole RK; Keene FR; Collins JG
    Chempluschem; 2018 Jul; 83(7):643-650. PubMed ID: 31950622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mononuclear Polypyridylruthenium(II) Complexes with High Membrane Permeability in Gram-Negative Bacteria-in particular Pseudomonas aeruginosa.
    Gorle AK; Feterl M; Warner JM; Primrose S; Constantinoiu CC; Keene FR; Collins JG
    Chemistry; 2015 Jul; 21(29):10472-81. PubMed ID: 26042390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eukaryotic Cell Toxicity and HSA Binding of [Ru(Me
    Sun B; Musgrave IF; Day AI; Heimann K; Keene FR; Collins JG
    Front Chem; 2018; 6():595. PubMed ID: 30560120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chlorido-containing ruthenium(II) and iridium(III) complexes as antimicrobial agents.
    Pandrala M; Li F; Feterl M; Mulyana Y; Warner JM; Wallace L; Keene FR; Collins JG
    Dalton Trans; 2013 Apr; 42(13):4686-94. PubMed ID: 23360972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The antimicrobial activity of inert oligonuclear polypyridylruthenium(II) complexes against pathogenic bacteria, including MRSA.
    Li F; Mulyana Y; Feterl M; Warner JM; Collins JG; Keene FR
    Dalton Trans; 2011 May; 40(18):5032-8. PubMed ID: 21442118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological properties of tetranuclear ruthenium complexes containing the bis[4(4'-methyl-2,2'-bipyridyl)]-1,7-heptane ligand.
    Sun B; Sundaraneedi MK; Southam HM; Poole RK; Musgrave IF; Keene FR; Collins JG
    Dalton Trans; 2019 Oct; 48(38):14505-14515. PubMed ID: 31531475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tri- and tetra-nuclear polypyridyl ruthenium(II) complexes as antimicrobial agents.
    Gorle AK; Feterl M; Warner JM; Wallace L; Keene FR; Collins JG
    Dalton Trans; 2014 Nov; 43(44):16713-25. PubMed ID: 25271478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein binding by dinuclear polypyridyl ruthenium(II) complexes and the effect of cucurbit[10]uril encapsulation.
    Li F; Feterl M; Warner JM; Day AI; Keene FR; Collins JG
    Dalton Trans; 2013 Jun; 42(24):8868-77. PubMed ID: 23657293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimicrobial Properties of Tris(homoleptic) Ruthenium(II) 2-Pyridyl-1,2,3-triazole "Click" Complexes against Pathogenic Bacteria, Including Methicillin-Resistant Staphylococcus aureus (MRSA).
    Kumar SV; Scottwell SØ; Waugh E; McAdam CJ; Hanton LR; Brooks HJ; Crowley JD
    Inorg Chem; 2016 Oct; 55(19):9767-9777. PubMed ID: 27657170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dinuclear ruthenium(ii) complexes with flexible bridges as non-duplex DNA binding agents.
    Morgan JL; Spillane CB; Smith JA; Buck DP; Collins JG; Keene FR
    Dalton Trans; 2007 Oct; (38):4333-42. PubMed ID: 17893823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dinuclear ruthenium(ii) complexes containing one inert metal centre and one coordinatively-labile metal centre: syntheses and biological activities.
    Li X; Heimann K; Li F; Warner JM; Richard Keene F; Grant Collins J
    Dalton Trans; 2016 Mar; 45(9):4017-29. PubMed ID: 26841356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastereomeric bactericidal effect of Ru(phenanthroline)
    Mårtensson AK; Bergentall M; Tremaroli V; Lincoln P
    Chirality; 2016 Nov; 28(11):713-720. PubMed ID: 27791316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro susceptibility and cellular uptake for a new class of antimicrobial agents: dinuclear ruthenium(II) complexes.
    Li F; Feterl M; Mulyana Y; Warner JM; Collins JG; Keene FR
    J Antimicrob Chemother; 2012 Nov; 67(11):2686-95. PubMed ID: 22865383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dinuclear polypyridylruthenium(II) complexes: flow cytometry studies of their accumulation in bacteria and the effect on the bacterial membrane.
    Li F; Feterl M; Warner JM; Keene FR; Collins JG
    J Antimicrob Chemother; 2013 Dec; 68(12):2825-33. PubMed ID: 23873648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress and antimicrobial activity of chromium(III) and ruthenium(II) complexes on Staphylococcus aureus and Escherichia coli.
    Páez PL; Bazán CM; Bongiovanni ME; Toneatto J; Albesa I; Becerra MC; Argüello GA
    Biomed Res Int; 2013; 2013():906912. PubMed ID: 24093107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of ruthenium(II) complexes as topical antibiotics against methicillin resistant Staphylococcus aureus.
    Lam PL; Lu GL; Hon KM; Lee KW; Ho CL; Wang X; Tang JC; Lam KH; Wong RS; Kok SH; Bian ZX; Li H; Lee KK; Gambari R; Chui CH; Wong WY
    Dalton Trans; 2014 Mar; 43(10):3949-57. PubMed ID: 24448670
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and Evaluation of In Vitro DNA/Protein Binding Affinity, Antimicrobial, Antioxidant and Antitumor Activity of Mononuclear Ru(II) Mixed Polypyridyl Complexes.
    Putta VR; Chintakuntla N; Mallepally RR; Avudoddi S; K N; Nancherla D; V V N Y; R S P; Surya SS; Sirasani S
    J Fluoresc; 2016 Jan; 26(1):225-40. PubMed ID: 26555289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between the structures of periphery ligands and the DNA binding mode of [Ru(II)(1,10-phenanthroline)(L1L2)dipyrido[3,2-a:2',3'-c]phenazine](n+) (L1=Cl or pyridine and L2=pyridine, n=1,2).
    Jang YJ; Yeo GY; Park B; Kim SK
    Biophys Chem; 2011 Sep; 158(1):38-45. PubMed ID: 21601346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans ruthenium(II) complexes with NH-bridged tetradentate symmetric and asymmetric polypyridyl ligands.
    Concepción J; Just O; Leiva AM; Loeb B; Rees WS
    Inorg Chem; 2002 Nov; 41(23):5937-9. PubMed ID: 12425616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.